MedPage Today on MSN
Who Knew? Autoimmunity Might Actually Benefit Some Cancer Patients
Some 68% of patients with autoimmune disease had "major" side effects from CAR-T therapy for myeloma, lymphoma, or leukemia, ...
CD19 chimeric antigen receptor (CAR) T-cell therapy showed potential in treating patients with refractory systemic lupus erythematosus (SLE), with B-cell depletion and disease activity reduction ...
By examining genomic variation more closely, scientists can now identify new disease connections with greater speed and accuracy. For centuries, scientists have recognized that certain illnesses can ...
With a closer look at genomic variation, scientists now have a faster, more precise way to uncover new links to disease EMBL ...
The night Basim Khandakji’s novel won the 2024 “Arabic Booker Prize”, Israeli prison guards stormed his cell, assaulted him, ...
Indiana has a relatively new law that bans cell phones in instructional settings, and schools are already seeing an impact.
What if bacteria are conscious? New research suggests all life experiences awareness through unique lenses—and humans can ...
The U.S. government has awarded Kernal Bio and three other sub-awardees up to $48 million to help advance the biotech’s in vivo mRNA-encoded CAR T-cell program. In an interesting—if not somewhat ...
"Our hearts go out to our builder Dave and his son Gene, who tragically lost their beautiful wife and mum, Carly, to ...
Detailed price information for Sellas Life Sciences Group Inc (SLS-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback